返回
The VRNetzer platform enables interactive network analysis in Virtual Reality
DOI:10.1038/s41467-021-22570-w.png)
摘要
En 中文
Networks provide a powerful representation of interacting components within complex systems, making them ideal for visually and analytically exploring big data. However, the size and complexity of many networks render static visualizations on typically-sized paper or screens impractical, resulting in proverbial 'hairballs'. Here, we introduce a Virtual Reality (VR) platform that overcomes these limitations by facilitating the thorough visual, and interactive, exploration of large networks. Our platform allows maximal customization and extendibility, through the import of custom code for data analysis, integration of external databases, and design of arbitrary user interface elements, among other features. As a proof of concept, we show how our platform can be used to interactively explore genome-scale molecular networks to identify genes associated with rare diseases and understand how they might contribute to disease development. Our platform represents a general purpose, VR-based data exploration platform for large and diverse data types by providing an interface that facilitates the interaction between human intuition and state-of-the-art analysis methods. Data-rich networks can be difficult to interpret beyond a certain size. Here, the authors introduce a platform that uses virtual reality to allow the visual exploration of large networks, while interfacing with data repositories and other analytical methods to improve the interpretation of big data.
Keyword:
HUMAN PHENOTYPE ONTOLOGY
GENES
PRIORITIZATION
WALKING
MODELS
TOOL
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
15.7
论文数:
9.4W
被引数:
91.2W
机构
引用论文
Next-generation diagnostics and disease-gene discovery with the Exomiser下一代诊断和疾病基因发现与Exomiser
NATURE PROTOCOLS
IF16
HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networksHIPPIE v2.0: 增强蛋白质-蛋白质相互作用网络的意义和可靠性
NUCLEIC ACIDS RESEARCH
IF13.1

